Tsvetelina Hoang

Tsvetelina Hoang

No open positions remaining
53 year
Health Technology
Consumer Services
Commercial Services

Profile

Tsvetelina Pencheva Hoang formerly worked at Bellicum Pharmaceuticals, Inc., as Director-Translational Research from 2015 to 2018, The Phi Beta Kappa Society, as Member, and Marker Therapeutics, Inc., as Vice President-Research & Development from 2018 to 2024.
Dr. Hoang received her doctorate degree from The Johns Hopkins University and undergraduate degree and graduate degree from Yale University.

Former positions of Tsvetelina Hoang

CompaniesPositionEnd
MARKER THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2024-07-31
BELLICUM PHARMACEUTICALS, INC. Corporate Officer/Principal 2018-06-30
Corporate Officer/Principal -
See the detail of Tsvetelina Hoang's experience

Training of Tsvetelina Hoang

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

17

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

  1. Stock Market
  2. Insiders
  3. Tsvetelina Hoang